Allison Transmission Inc. is counting on upgrades to truck and bus fleets in countries like China and India for its future growth, the company revealed in a filing it made Friday to raise up to $750 million through an initial public offering.
Allison Transmission Inc.'s enormous debt load is probably one factor driving the company to consider a public offering, an investment analyst said Monday morning.
Shares of biotechnology company Endocyte Inc. rose in afternoon trading Friday, after the company slashed pricing expectations for its initial public offering.
The West Lafayette-based biopharmaceutical company now is planning to offer at least 12.5 million shares, or 17 percent more than previously announced, but at a lower price of $6 each.
The West Lafayette-based drug development firm intends to sell 6.15 million shares for $13 to $15 apiece. That would fetch $80 million to $92 million.
General Motors' return to Wall Street was well received Thursday, as the company’s stock closed up 3.6 percent in its initial public offering.
Stock in the Fort Wayne-based company began trading Thursday morning at $16 but climbed as high as $23.90.
The Fort Wayne-based company is scheduled to begin trading as a public company Wednesday morning. The estimated offering price is $14 to $16 each, although a Morningstar analyst predicts the IPO could bring as much as $18 a share.
Venture capitalists in Indiana and nationally have thrown money at the company with abandon. Local investors include CID Capital,
Clarian Health Ventures and the Indiana Future Fund.
The company, headquartered at Purdue Research Park, said the number of shares to be offered and their price range have yet
to be determined.
The 28-year-old company reported profit in its latest fiscal year of $43.2 million on $288.9 million in sales.
There’s a reason we’re thrilled to see the Indianapolis area is building a healthy pipeline
of firms primed to go public: It bodes well for our economy.
Several Indiana companies are in a position, or soon will be, to launch an initial public offering. But don’t expect a wave
of new Indiana public companies. In the recession, with both revenue and profits down, companies may choose to wait until
they have better numbers to report.
Robust growth at marketing software maker Aprimo is fueling speculation it is about to make another run at going public, and
co-founder Bill Godfrey said he won’t rule out the possibility of an IPO.
The Carmel-based auctioneer had expected to raise $340.9 million through its IPO, but the company said it would sell 25 million common shares at $12 each for total proceeds of $300 million.
Macquarie Office Trust of Sydney has quietly pulled the 48-story Chase Tower off the market, along with a property in Boston and a property in Denver that failed to draw juicy enough offers.
If nothing else, you have to admire the patience shown by ExactTarget and Aprimo, two of the area’s hottest tech companies,
as they await better conditions to launch their initial public offerings.
Dick Beltzhoover, a private investor in Omnicity Corp., a Carmel-based wireless broadband provider, has quietly taken the
company public and has lofty plans to expand nationwide.
